KR900001382A - 연속 셀라인에서의 ibdv생성 - Google Patents

연속 셀라인에서의 ibdv생성 Download PDF

Info

Publication number
KR900001382A
KR900001382A KR1019890010255A KR890010255A KR900001382A KR 900001382 A KR900001382 A KR 900001382A KR 1019890010255 A KR1019890010255 A KR 1019890010255A KR 890010255 A KR890010255 A KR 890010255A KR 900001382 A KR900001382 A KR 900001382A
Authority
KR
South Korea
Prior art keywords
ibdv
cell line
vaccine
derived
mammalian cell
Prior art date
Application number
KR1019890010255A
Other languages
English (en)
Other versions
KR0156732B1 (ko
Inventor
반 데르 마렐 피에트
게랄더스 무렌 피에터
Original Assignee
에.지.제.베르메렌·에프.지.엠.헤르만스
악조 엔 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19852657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR900001382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에.지.제.베르메렌·에프.지.엠.헤르만스, 악조 엔 브이. filed Critical 에.지.제.베르메렌·에프.지.엠.헤르만스
Publication of KR900001382A publication Critical patent/KR900001382A/ko
Application granted granted Critical
Publication of KR0156732B1 publication Critical patent/KR0156732B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

연속 셀라인에서의 IBDV생성
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 감염성 점액낭염 비루스(IBDV)를 감염된 포유동물의 셀라인으로부터 IBDV항원물질이 유도됨을 특징으로 하는, IBDV항원물질을 함유한 감염성 점액낭염 비루스(IBDV)백신.
  2. 제1항에 있어서, 포유동물 셀라인은 원숭이 셀라인 임을 특징으로 하는 IBDV백신.
  3. 제2항에 있어서, 원숭이 셀라인은 Vero셀라인 임을 특징으로 하는 IBDV백신.
  4. 제1항 내지 제3항중 어느 한항에 있어서, 항원 물질이 비활성화됨을 특징으로 하는 IBDV백신.
  5. 제1항 내지 제4항중 어느 한항에 따른 백신을 조류에게 투여함을 특징으로 하는 감염성 점액낭염에 대한 가금의 면역화 방법.
  6. 제5항에 있어서, 모IBDV로 감염된 포유동물 셀라인으로부터 유도된 비활성화 IBDV항원을 함유하는 백신으로 모(어미)동물을 백신화함을 특징으로 하는 방법.
  7. 제5항에 있어서, 모동물로부터 유도된 IBDV에 대한 항체를 함유한 새끼조류를 IBDV로 감염된 포유동물 셀라인으로부터 유도된 생 IBDV를 함유한 백신으로 백신화함을 특징으로 하는 방법.
  8. IBDV로 감염된 포유동물 셀라인으로부터 유도된 비활성화 IBDV항원물질, 비루스, 박테리아 및 기생충으로 구성되는 그룹으로부터 선택된 하나 이상의 미생물로부터의 항원물질을 함유한 조합백신.
  9. IBDV로 감염된 포유동물 셀라인으로부터 유도된 생 IBDV, 및 또다른 생비루스를 함유한 조합백신.
  10. 세포 기질로서 포유동물 셀라인을 사용하는 것을 특징으로 하는 세포 배양에서 IBDV을 생성하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890010255A 1988-07-21 1989-07-20 연속 셀 라인에서의 ibdv 생성 KR0156732B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8801843 1988-07-21
NL8801843 1988-07-21

Publications (2)

Publication Number Publication Date
KR900001382A true KR900001382A (ko) 1990-02-27
KR0156732B1 KR0156732B1 (ko) 1998-11-16

Family

ID=19852657

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890010255A KR0156732B1 (ko) 1988-07-21 1989-07-20 연속 셀 라인에서의 ibdv 생성

Country Status (12)

Country Link
US (3) US5192539A (ko)
EP (1) EP0352835B1 (ko)
JP (1) JP2749887B2 (ko)
KR (1) KR0156732B1 (ko)
CN (1) CN1038728C (ko)
AU (1) AU628063B2 (ko)
CA (1) CA1331444C (ko)
DE (1) DE68919449T2 (ko)
ES (1) ES2067528T3 (ko)
HU (3) HU218738B (ko)
NZ (1) NZ229997A (ko)
ZA (1) ZA895232B (ko)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5919461A (en) * 1989-10-18 1999-07-06 Akzo Nobel N.V. Nonpathogenic infectious bursal disease virus and vaccine
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
DK1314431T3 (da) 1993-04-30 2008-11-10 Wellstat Biologics Corp Oprensede sammensætninger af Newcastle disease virus
PT833934E (pt) 1995-06-15 2005-02-28 Crucell Holland Bv Sistemas de empacotamento para adenovivrus recombinente humano destinados a terapia genetica
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
EP0861665A1 (en) * 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
TWI220904B (en) 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US20060099685A1 (en) * 1999-04-15 2006-05-11 Yallop Christopher A Recombinant expression of factor VIII in human cells
US7297680B2 (en) * 1999-04-15 2007-11-20 Crucell Holland B.V. Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
US20050164386A1 (en) * 1999-04-15 2005-07-28 Uytdehaag Alphonsus G. Overexpression of enzymes involved in post-translational protein modifications in human cells
US8236561B2 (en) * 1999-04-15 2012-08-07 Crucell Holland B.V. Efficient production of IgA in recombinant mammalian cells
US7604960B2 (en) * 1999-04-15 2009-10-20 Crucell Holland B.V. Transient protein expression methods
WO2003048348A2 (en) * 2001-12-07 2003-06-12 Crucell Holland B.V. Production of viruses, viral isolates and vaccines
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
US7527961B2 (en) * 1999-11-26 2009-05-05 Crucell Holland B.V. Production of vaccines
US7192759B1 (en) 1999-11-26 2007-03-20 Crucell Holland B.V. Production of vaccines
ZA200104596B (en) 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
DK1623023T3 (da) * 2003-05-09 2009-03-02 Crucell Holland Bv Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
AU2004240782B2 (en) * 2003-05-23 2011-04-21 Crucell Holland B.V. Production of recombinant IGM in per.C6 cells
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
CN1930284B (zh) 2004-03-12 2010-06-23 惠氏公司 传染性囊病病毒抗原分离株和疫苗
GB0822590D0 (en) 2008-12-11 2009-01-21 Materialise Nv Orthotic prosthetic cushioned device and method of making the same
GB0911953D0 (en) 2009-07-09 2009-08-19 Materialise Nv An artificial exoskeleton device, an orthotic or a prosthetic device comprising an integrated hinge structure
WO2011007002A1 (en) 2009-07-17 2011-01-20 Materialise N.V. Surgical guiding tool, methods for manufacture and uses thereof
GB0915948D0 (en) 2009-09-11 2009-10-28 Materialise Nv Surgical, therapeutic or diagnostic tool
GB0915947D0 (en) 2009-09-11 2009-10-28 Materialise Nv Adaptable therapeutic, diagnostic or surgical guide
US9498234B2 (en) 2009-12-29 2016-11-22 Mobelife Nv Customized surgical guides, methods for manufacturing and uses thereof
GB0922640D0 (en) 2009-12-29 2010-02-10 Mobelife Nv Customized surgical guides, methods for manufacturing and uses thereof
GB201001985D0 (en) 2010-02-05 2010-03-24 Materialise Nv Guiding instruments and impactors for an acetabular cup implant, combinations therof, methods for manufacturing and uses thereof
GB201002778D0 (en) 2010-02-18 2010-04-07 Materialise Dental Nv 3D digital endodontics
GB201007255D0 (en) 2010-04-29 2010-06-16 Materialise Nv Self-retracting actuator
GB201007257D0 (en) 2010-04-29 2010-06-16 Materialise Nv Improved fixating component for a fixture
GB201009116D0 (en) 2010-06-01 2010-07-14 Materialise Nv Acetabular cup reamer
US20140046332A1 (en) 2011-04-28 2014-02-13 Ayishwariya Premanathan Stopping tool guides and combinations thereof with surgical guides, methods for manufacturing and uses thereof
GB201107385D0 (en) 2011-05-04 2011-06-15 Materialise Nv Medical imaging calibration device
WO2012152900A1 (en) 2011-05-12 2012-11-15 Materialise N.V. Methods and devices for validating the position of patient-specific devices
GB201108078D0 (en) 2011-05-16 2011-06-29 Materialise Nv Surgical guides and methods for manufacturing thereof
EP2529677A1 (en) 2011-05-30 2012-12-05 Materialise NV Patient-specific surgical guiding tools, methods for manufacture
CN102258777B (zh) * 2011-06-30 2012-09-26 河南农业大学禽病研究所 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法
EP2731512B1 (en) 2011-07-12 2020-10-07 Materialise N.V. Method of manufacturing a surgical instrument for the positioning of an alignment element
US10052114B2 (en) 2011-07-12 2018-08-21 Materialise, Nv Shoulder base plate coverage and stability
BE1020070A5 (nl) 2011-07-12 2013-04-02 Materialise Nv Chirurgisch instrument voor de positionering van een uitlijnelement.
WO2013017647A1 (en) 2011-08-02 2013-02-07 Materialise Nv Additive manufacturing of openings with reduced dimensions
GB201113506D0 (en) 2011-08-05 2011-09-21 Materialise Nv Impregnated lattice structure
WO2013041618A1 (en) 2011-09-20 2013-03-28 Materialise N.V. Multifunctional patient - specific guides
EP2757978B1 (en) 2011-09-21 2016-08-17 Materialise N.V. Patient-specific surgical guide
WO2013050525A1 (en) 2011-10-07 2013-04-11 Materialise N.V. Methods for the manufacture of intraluminal endoprosthesis
WO2013050524A1 (en) 2011-10-07 2013-04-11 Materialise Nv Additive manufacturing of tiled objects
DK2670314T3 (en) 2011-10-28 2014-11-17 Materialise Nv COVERAGE AND STABILITY OF A SHOULDER BASIS PLATE
EP2770920B1 (en) 2011-10-28 2017-07-19 Materialise N.V. Shoulder guides
BE1021757B1 (nl) 2011-10-28 2016-01-15 Materialise N.V. Geleiders met drukpunten
WO2013072097A1 (en) 2011-11-14 2013-05-23 Materialise Shoe closure system
JP2013116869A (ja) * 2011-12-02 2013-06-13 Vaxxinova Kk 細胞内在ウイルスを主成分とする伝染性ファブリキウス嚢病生ワクチン
WO2013093645A2 (en) 2011-12-23 2013-06-27 Materialise Nv Systems and methods for designing and generating devices using accuracy maps and stability analysis
WO2013098232A1 (en) 2011-12-28 2013-07-04 Materialise N.V. Apparatus for introducing an anchoring device
WO2013104682A1 (en) 2012-01-11 2013-07-18 Materialise N.V. Implant placement guide
AU2013244902B2 (en) 2012-04-05 2016-04-21 Materialise N.V. Instrument and method for bone fixation
WO2013156545A1 (en) 2012-04-18 2013-10-24 Materialise N.V. Orthopedic bone fixation systems and methods
US20150112443A1 (en) 2012-05-14 2015-04-23 Mobelife N.V. Implantable bone augment and method for manufacturing an implantable bone augment
WO2014019998A1 (en) 2012-07-30 2014-02-06 Materialise Nv Systems and methods for forming and utilizing bending maps for object design
EP2710978B1 (en) 2012-09-21 2017-11-29 Materialise N.V. Patient-specific intraluminal implants
JP6270856B2 (ja) 2012-10-05 2018-01-31 マテリアライズ エン．フェー． カスタマイズされた大動脈ステントデバイスおよびそれを作製する方法
WO2014076157A1 (en) 2012-11-14 2014-05-22 Materialise N.V. Pre-tensioned bone anchors and methods of using and manufacturing the same
WO2014090908A1 (en) 2012-12-14 2014-06-19 Materialise N.V. Surgical guiding tools for orthopedic surgery and systems and methods of manufacturing the same
WO2014095853A1 (en) 2012-12-17 2014-06-26 Materialise N.V. Method for designing a surgical guide
US10010431B2 (en) 2013-03-27 2018-07-03 Materialise N.V. Customized surgical guide
BR112016004136B1 (pt) * 2013-08-30 2023-04-11 Km Biologics Co., Ltd. Métodos para produzir um vírus em uma cultura celular e para a preparação de uma vacina
EP2856951A1 (en) 2013-10-03 2015-04-08 Materialise N.V. Surgical guide system
WO2015082023A1 (en) 2013-12-06 2015-06-11 Mobelife N.V. Method for manufacturing an implantable bone augment
WO2016102027A1 (en) 2014-12-24 2016-06-30 Mobelife N.V. Method of using a computing device for providing a design of an implant
WO2016102025A1 (en) 2014-12-24 2016-06-30 Mobelife N.V. Bone implant and a method for its manufacture comprising generating a plurality of fixation configurations
EP3389568A2 (en) 2015-12-17 2018-10-24 Materialise N.V. Pre-operative determination of implant configuration for soft-tissue balancing in orthopedic surgery
EP3315098A1 (en) 2016-10-25 2018-05-02 Université Libre de Bruxelles Fracture braces
JP7285777B2 (ja) 2016-12-21 2023-06-02 ウラブ・システムズ，インコーポレイテッド 歯科矯正計画策定システム
RU2736888C2 (ru) * 2018-12-10 2020-11-23 Федеральное государственное бюджетное научное учреждение Федеральный научный центр "Всероссийский научно-исследовательский и технологический институт птицеводства" Российской академии наук Штамм "dd1" вируса инфекционной бурсальной болезни кур семейства birnaviridae, рода avibirnavirus, 1 серотипа для производства инактивированных сорбированных и эмульгированных вакцин

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US86025A (en) * 1869-01-19 Improved wood pavement
DE2045160C3 (de) * 1970-09-12 1975-04-10 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
US5602022A (en) 1997-02-11
DE68919449T2 (de) 1995-05-04
KR0156732B1 (ko) 1998-11-16
HU218738B (hu) 2000-11-28
US5192539A (en) 1993-03-09
AU3825289A (en) 1990-01-25
JPH0278634A (ja) 1990-03-19
CN1038728C (zh) 1998-06-17
CA1331444C (en) 1994-08-16
AU628063B2 (en) 1992-09-10
HU211246A9 (en) 1995-11-28
NZ229997A (en) 1991-11-26
HUT51904A (en) 1990-06-28
ES2067528T3 (es) 1995-04-01
ZA895232B (en) 1990-04-25
DE68919449D1 (de) 1995-01-05
JP2749887B2 (ja) 1998-05-13
EP0352835A1 (en) 1990-01-31
US6129920A (en) 2000-10-10
EP0352835B1 (en) 1994-11-23
CN1039359A (zh) 1990-02-07

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
KR927003798A (ko) 재조합 폭스비루스 내부 코아
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
FR2602791B1 (fr) Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
ES548397A0 (es) Un metodo para producir normas orales frente a virus de hepatitis-b.
ATE7855T1 (de) Herstellung von virusantigenen.
Martin et al. Characteristics of bovine mammillitis virus
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
KR930006150A (ko) 닭 빈혈증 병원체 백신
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
YU242390A (sh) Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena
EP0339668A3 (en) Hepatitis a virus antigen
Nazerian et al. Immunoferritin studies of Marek's disease virus directed intracellular and membrane antigens
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
ES486441A0 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
KR900017611A (ko) 개의 코로나 바이러스 백신
Wiktor et al. Detection of a lymphocytic choriomeningitis component in rabies virus preparations
KR900001374A (ko) Bu-3608을 이용한 인체면역결핍 바이러스에 대한 항바이러스 방법
KR840001834A (ko) 감보로 생독 백신의 제조방법
KINJO et al. IN VITRO TRANSFORMATION OF HAMSTER CELLS BY
KR920009980A (ko) 신균주 nd dsb hp주 및 이로부터 닭뉴캣슬병 내열성 백신을 제조하는 방법
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
EP0145589A3 (fr) Culture de cellules eucaryotes productrices d'une protéine vaccinante, notamment d'antigène HBs
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050720

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee